
Insiliance provides AI-powered insights to repurpose CNS drugs and optimize treatments. It uses machine learning models and computational biology to analyze biology, chemistry, and clinical data. The platform targets pharmaceutical and biotech companies seeking faster, data-driven CNS drug repositioning and therapy optimization. Core technologies include AI, machine learning, and computational biology, with integrations into research workflows and drug discovery tools. The market focus is pharma R&D, aiming to scale CNS therapies with data-driven decision making.

Insiliance provides AI-powered insights to repurpose CNS drugs and optimize treatments. It uses machine learning models and computational biology to analyze biology, chemistry, and clinical data. The platform targets pharmaceutical and biotech companies seeking faster, data-driven CNS drug repositioning and therapy optimization. Core technologies include AI, machine learning, and computational biology, with integrations into research workflows and drug discovery tools. The market focus is pharma R&D, aiming to scale CNS therapies with data-driven decision making.